553 related articles for article (PubMed ID: 25904543)
1. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
2. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
3. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
4. Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol.
Yang QY; Cao QQ; Qin QP; Deng CX; Liang H; Chen ZF
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949884
[TBL] [Abstract][Full Text] [Related]
5. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
[TBL] [Abstract][Full Text] [Related]
6. Study on potential antitumor mechanism of a novel Schiff base copper(II) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity.
Qiao X; Ma ZY; Xie CZ; Xue F; Zhang YW; Xu JY; Qiang ZY; Lou JS; Chen GJ; Yan SP
J Inorg Biochem; 2011 May; 105(5):728-37. PubMed ID: 21463568
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Structure Characterization and Antitumor Activity Study of a New Iron(III) Complex of 5-Nitro-8-hydroxylquinoline (HNOQ).
Zhang HR; Meng T; Liu YC; Qin QP; Chen ZF; Liu YN; Liang H
Chem Pharm Bull (Tokyo); 2016 Aug; 64(8):1208-17. PubMed ID: 27238362
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
[TBL] [Abstract][Full Text] [Related]
9. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
Deng J; Gou Y; Chen W; Fu X; Deng H
Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
11. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
12. Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.
Megger DA; Rosowski K; Radunsky C; Kösters J; Sitek B; Müller J
Dalton Trans; 2017 Apr; 46(14):4759-4767. PubMed ID: 28338141
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor.
Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H
Eur J Med Chem; 2018 Jan; 143():1597-1603. PubMed ID: 29133054
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ
Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.
Gou Y; Zhang Y; Qi J; Zhou Z; Yang F; Liang H
J Inorg Biochem; 2015 Mar; 144():47-55. PubMed ID: 25573806
[TBL] [Abstract][Full Text] [Related]
16. DNA interaction, antioxidant activity, and bioactivity studies of two ruthenium(II) complexes.
Han BJ; Jiang GB; Yao JH; Li W; Wang J; Huang HL; Liu YJ
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():840-9. PubMed ID: 25150435
[TBL] [Abstract][Full Text] [Related]
17. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.
Deng J; Chen W; Deng H
J Fluoresc; 2016 Nov; 26(6):1987-1996. PubMed ID: 27488686
[TBL] [Abstract][Full Text] [Related]
19. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.
Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL
Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805
[TBL] [Abstract][Full Text] [Related]
20. Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?
Krishnamoorthy P; Sathyadevi P; Butorac RR; Cowley AH; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2012 Apr; 41(15):4423-36. PubMed ID: 22344370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
